Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: A report of three cases

Reproductive BioMedicine Online

Volumn 29, Issue 5, 2014, Pages 541-544

  Gurbuz, Ali Sami ^a   Gode, Funda ^b   Ozcimen, Necati ^a   Isik, Ahmet Zeki ^b  

^a Novafertil IVF Centre   (Turkey)

^b IRENBE IVF Center   (Turkey)

Author keywords

freeze all; GnRH agonist; OHSS; segmentation; trigger

Indexed keywords

ALBUMIN; CABERGOLINE; CETRORELIX; ESTRADIOL; LEUPRORELIN; LOW MOLECULAR WEIGHT HEPARIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; CHORIONIC GONADOTROPIN; GONADORELIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; CASE REPORT; CRYOPRESERVATION; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYSTEROSALPINGOGRAPHY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LOWER ABDOMINAL PAIN; LUTEINIZING HORMONE BLOOD LEVEL; NAUSEA AND VOMITING; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PARACENTESIS; SPERMATOZOON ABNORMALITY; AGONISTS; ANALOGS AND DERIVATIVES; COMPLICATION; EMBRYO TRANSFER; INFERTILITY, FEMALE; METABOLISM; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PROCEDURES;

ADULT; CHORIONIC GONADOTROPIN; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 84908397852     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.07.022     Document Type: Article

References (15)

1. Bodri D., Guillen J.J., Galindo A., Mataro D., Pujol A., and Coll O. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil. Steril 91 2009 365 371
2. Devroey P., Polyzos N.P., and Bockell C. An OHSS-free clinic by segmentation of IVF treatment Hum. Reprod 10 2011 2593 2597
3. Fatemi H.M., Popovic-Todorovic B., Humaidan P., Kol S., Banker M., Devroey P., and Garcia-Velasco A. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and freeze-all approach in GnRH antagonist protocol Fertil. Steril 101 2014 1008 1011
4. Griesinger G., Otte S., Schroer A., Ludwig A.K., Diedrich K., Al-Hasani S., and Schultze-Mosgau A. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study Hum. Reprod 22 2007 1348 1352
5. Griesinger G., Schultz L., Bauer T., Broessner A., Frambach T., and Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study Fertil. Steril 95 2011 2029 2033
6. Haas J., Ophir L., Barzilay E., Yerushalmi G.M., Yung Y., Kedem A., Maman E., and Hourvitz A. GnRH agonist vs. hCG for triggering of ovulation - differential effects on gene expression in human granulosa cells PLoS ONE 9 2014 e90359
7. Humaidan P., Quartarolo J., and Papanikolaou E.G. Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil. Steril 94 2010 389 400
8. Iliodromiti S., Blockeel C., Tremellen K.P., Fleming R., Tournaye H., Humaidan P., and Nelson S.M. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study Hum. Reprod 28 2013 2529 2536
9. Kol S., and Humaiden P. GnRH agonist triggering: recent developments Reprod. Biomed. Online 28 2013 226 230
10. Lainas G.T., Kolibianakis E.M., Sfontouris I.A., Zorzovillis I.Z., Petsas G.K., Lainas T.G., and Tarlatzis B.C. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS Hum. Reprod 28 2013 1929 1942
11. Leitao V.M.S., Moroni R.F., Seko L.M.D., Nastri C.O., and Martins W.P. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials Fertil. Steril 101 2014 664 675
12. Montanelli L., Delbaere A., Carlo C.D., Nappi C., Smits G., Vassart G., and Costagliola S. A mutation in the follicle stimulating hormone receptor as a cause of familial ovarian hyperstimulation syndrome J. Clin. Endocrinol. Metab 89 2004 1255 1258
13. Papanikolaou E.G., Pozzobon C., Kolibianakis E.M., Camus M., Tournaye H., Fatemi H.M., Van Steirteghem A., and Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in woman undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil. Steril 85 2006 112 120
14. Sahin L., and Yavuzcan A. Recurrent spontaneous ovarian hyperstimulation in a virgin girl Ginekol. Pol 84 2013 647 649
15. Seyhan A., Ata B., Polat M., Son W.Y., Yarali H., and Dahan M.H. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG Hum. Reprod 28 2013 2522 2528